Recital 8, Regulation (EU) 2026/794

In forcesince 27 Mar 2026

Annex II, Part 5, Chapters II and III, to Delegated Regulation (EU) 2020/686 lay down requirements as regards infection with bluetongue virus (serotypes 1-24) and infection with the epizootic haemorrhagic disease virus. The requirements for those diseases should be amended taking account of the re-categorisation from a category C+D+E disease to a category D+E disease of infection with bluetongue virus (serotypes 1-24) in the Annex to Implementing Regulation (EU) 2018/1882.